Pills, Injections, Rings, or Implants? PrEP Formulation Preferences of PrEP-Experienced African Women for HIV Prevention

Kenneth Ngure^{1

2}, Nelly R Mugo^{2

3}, Elizabeth A Bukusi^{2

4

5}, Catherine Kiptinness³, Kevin Oware⁴, Stephen Gakuo³, Nicholas Musinguzi⁶, Maria Pyra⁷, Lindsey Garrison⁸, Jared M Baeten^{2

9

10

11}, Jessica E Haberer^{8

12}

Affiliations

¹ Department of Community Health, Jomo Kenyatta University of Agriculture and Technology, Nairobi, Kenya.
² Department of Global Health, University of Washington, Seattle, WA.
³ Center for Clinical Research, Kenya Medical Research Institute, Nairobi, Kenya.
⁴ Center for Microbiology Research, Kenya Medical Research Institute, Nairobi, Kenya.
⁵ Department of Obstetrics and Gynecology, University of Washington, Seattle, WA.
⁶ Global Health Collaborative, Mbarara University of Science and Technology, Mbarara, Uganda.
⁷ University of Chicago, Chicago, IL.
⁸ Massachusetts General Hospital, Center for Global Health, Boston, MA.
⁹ Department of Epidemiology, University of Washington, Seattle, WA.
¹⁰ Department of Medicine, University of Washington, Seattle, WA.
¹¹ Gilead, Foster City, CA.
¹² Harvard Medical School, Department of Medicine, Boston, MA.

Kenneth Ngure et al. J Acquir Immune Defic Syndr. 2021.

. 2021 Dec 1;88(4):e30-e32.

doi: 10.1097/QAI.0000000000002793.

¹ Department of Community Health, Jomo Kenyatta University of Agriculture and Technology, Nairobi, Kenya.
² Department of Global Health, University of Washington, Seattle, WA.
³ Center for Clinical Research, Kenya Medical Research Institute, Nairobi, Kenya.
⁴ Center for Microbiology Research, Kenya Medical Research Institute, Nairobi, Kenya.
⁵ Department of Obstetrics and Gynecology, University of Washington, Seattle, WA.
⁶ Global Health Collaborative, Mbarara University of Science and Technology, Mbarara, Uganda.
⁷ University of Chicago, Chicago, IL.
⁸ Massachusetts General Hospital, Center for Global Health, Boston, MA.
⁹ Department of Epidemiology, University of Washington, Seattle, WA.
¹⁰ Department of Medicine, University of Washington, Seattle, WA.
¹¹ Gilead, Foster City, CA.
¹² Harvard Medical School, Department of Medicine, Boston, MA.

No abstract available

Conflict of interest statement

The authors have no conflicts of interest to disclose.

1. Global HIV & AIDS statistics — 2020 fact sheet https://www.unaids.org/en/resources/fact-sheet - Accessed on September 15, 2020
1. UNAIDS. Women and HIV: a spotlight on adolescent girls and young women. UNAIDS. 2019. https://www.unaids.org/en/resources/documents/2019/women-and-hiv Accessed on September 15, 2020
1. Dellar RC, Dlamini S, Karim QA. Adolescent girls and young women: key populations for HIV epidemic control. J Int AIDS Soc 2015;18(2 Suppl 1):19408. - PMC - PubMed
1. Baeten JM, Donnell D, Ndase P, et al. Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. N Engl J Med. 2012;367(5):399–410. - PMC - PubMed
1. Thigpen MC, Kebaabetswe PM, Paxton LA, et al. Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana. N Engl J Med. 2012;367(5):423–34. - PubMed